Quipt Home Medical Corp. (QIPT)
NASDAQ: QIPT · Real-Time Price · USD
2.270
-0.060 (-2.58%)
Apr 1, 2025, 10:33 AM EDT - Market open
Quipt Home Medical Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Quipt Home Medical stock have an average target of 6.50, with a low estimate of 6.00 and a high estimate of 7.00. The average target predicts an increase of 186.34% from the current stock price of 2.27.
Analyst Consensus: Strong Buy
* Price targets were last updated on Aug 21, 2024.
Analyst Ratings
The average analyst rating for Quipt Home Medical stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 |
---|---|---|---|---|---|---|
Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Hold | 1 | 1 | 1 | 1 | 1 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 3 | 3 | 3 | 3 | 3 | 2 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Benchmark | Benchmark | Strong Buy Maintains $9 → $7 | Strong Buy | Maintains | $9 → $7 | +208.37% | Aug 21, 2024 |
Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $8 → $6 | Strong Buy | Maintains | $8 → $6 | +164.32% | Aug 16, 2024 |
Benchmark | Benchmark | Strong Buy Maintains $10 → $9 | Strong Buy | Maintains | $10 → $9 | +296.48% | May 20, 2024 |
Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $9 → $8 | Strong Buy | Maintains | $9 → $8 | +252.42% | May 17, 2024 |
Raymond James | Raymond James | Buy → Hold Downgrades $10 | Buy → Hold | Downgrades | $10 | +340.53% | Feb 16, 2024 |
Financial Forecast
Revenue This Year
254.15M
from 245.92M
Increased by 3.35%
Revenue Next Year
267.84M
from 254.15M
Increased by 5.39%
EPS This Year
-0.08
from -0.16
EPS Next Year
-0.06
from -0.08
Revenue Forecast
Revenue | 2025 | 2026 | 2027 |
---|---|---|---|
High | 262.5M | 281.6M | 299.8M |
Avg | 254.2M | 267.8M | 276.9M |
Low | 242.4M | 247.3M | 252.3M |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 |
---|---|---|---|
High | 6.7% | 10.8% | 11.9% |
Avg | 3.3% | 5.4% | 3.4% |
Low | -1.4% | -2.7% | -5.8% |
EPS Forecast
EPS | 2025 | 2026 | 2027 |
---|---|---|---|
High | 0.05 | 0.01 | 0.02 |
Avg | -0.08 | -0.06 | -0.05 |
Low | -0.17 | -0.15 | -0.12 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 |
---|---|---|---|
High | - | - | - |
Avg | - | - | - |
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.